Almokalant glucuronidation in human liver and kidney microsomes: evidence for the involvement of UGT1A9 and 2B7

References

• ANDERSSON, T. B., SJoBERG, H., HOFFMANN, K.-J., BOOBIS, A. R., WATTS, P., EDWARDS, R. J., LAKE, B. G., PRICE, R. J., RENWICK, A. B., GómEz-LEcHóN, M. J., CASTELL, J. V., INGELMAN-SUNDBERG, M., HIDESTRAND, M., GOLDFARB, P. S., LEWIS, D. F. V., CORCOS, L., GUILLOUZO, A., TAAVITSAINEN, P. and PELKONEN, 0., 2001, An assessment of human liver-derived in vitro systems to predict the in vivo metabolism and clearance of almokalant. Drug Metabolism and Disposition, 29, 712–720.
   Google Scholar
• BAÁRNHIELM, C. and SOTHEL L., 1993, Pharmacokinetics and metabolism of 3H-labelled almokalant administered to healthy subjects as oral and intravenous solutions. Internal Report No. Z-003 (Astra Hassle: AstraZeneca Mölndal R&D).
   Google Scholar
• BOCK, K. W., FORSTER, A., GSCHAIDMEIER, H., BRUCK, M., MUNZEL, P., SCHARECK, W., FOURNEL-GIGLEUX, S. and BURCHELL, B., 1993, Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyltransferases. Biochemical Pharmacology, 45, 1809–1814.
   Google Scholar
• BURCHELL, B., 2003, Genetic variation of human UDP-glucuronosyltransferase: implications in disease and drug glucuronidation. American Journal of Pharmacogeonomics, 3, 37–52.
   PubMedGoogle Scholar
• BURCHELL, B., BRIERLEY, C. H. and RANCE, D., 1995, Specificity of UDP-glucuronosyltransferases and xenobiotic glucuronidation. Life Sciences, 57, 1809–1814.
   Google Scholar
• BURCHELL, B., COUGHTRIE, M., JACKSON, M., HARDING, D., FOURNEL-GIGLEUX, S., LEAKEY, J. and HUME, R., 1989, Development of human liver UDP-glucuronosyltransferases. Developments in Pharmacology and Therapeutics, 13, 70–77.
   Google Scholar
• BURCHELL, B., McGuroc, K., BRIERLEY, C. H. and CLARKE, D. J., 1997, UDP-Glucuronosyl-transferases. In F. P. Guengerich (ed.), Biotransformation, Vol. 3: Comprehensive Toxicology, I. G. Sipes, C. A. McQueen and A. J. Gandolfi (eds) (Oxford: Elsevier Science), pp. 201–435.
   Google Scholar
• COUGHTRIE, M. W. H., BURCHELL, B. and BEND, J. R., 1986, A general assay for UDP-glucuronosyltransferase activity using polar amino-cyano stationary phase HPLC and UDP[U-14C]glucuronic acid. Analytical Biochemistry, 159, 198–205.
   Google Scholar
• COUGHTRIE, M. W. H., BURCHELL, B. and BEND, J. R., 1987, Purification and properties of rat kidney UDP-glucuronosyltransferase. Biochemical Pharmacology, 36, 245–251.
   Google Scholar
• EBNER, T. and BURCHELL, B., 1993, Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family. Drug Metabolism and Disposition, 21, 50–55.
   PubMed Web of Science ®Google Scholar
• ETHELL, B. T., ANDERSON, G. D., BEAUMONT, K., RANCE, D. J. and BURCHELL, B., 1998, A universal radiochemical high-performance liquid chromatographic assay for the determination of UDP-glucuronosyltransferase activity. Analytical Biochemistry, 255, 142–147.
   PubMedGoogle Scholar
• ETHELL, B. T., BEAUMONT, K., RANCE, D. J. and BURCHELL, B., 2000, Use of cloned and expressed human UDP-glucuronosyltransferases for the assessment of human drug conjugation and identification of potential drug interactions. Drug Metabolism and Disposition, 29, 48–53.
   Google Scholar
• FOURNEL-GIGLEUX, S., SUTHERLAND, L., SABOLOVIC, N., BURCHELL, B. and SIEST, G., 1991, Stable expression of two human UDP-glucuronosyltransferase cDNAs in V79 cell cultures. Molecular Pharmacology, 39, 177–183.
   PubMed Web of Science ®Google Scholar
• HOFFMANN, K.-J. and GABRIELSSON, M., 1992, Almokalant metabolism in man studied by LC-MS ionspray quadrupole mass spectrometry (Abstract). In LC-MS Conference, 3-6 November 1992, Montreux, Switzerland.
   Google Scholar
• JIN, C., MINERS, J. 0., LILLYWHITE, K. J. and MACKENZIE, P., 1993, Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs. Journal of Pharmacology and Experimental Therapeutics, 264, 475–479.
   Google Scholar
• KENNEDY, T., 1997, Managing the drug discovery/development interface. Drug Discovery Today, 2, 436–444.
   Web of Science ®Google Scholar
• LAEMMLI, U. K., 1970, Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature, 227, 680–685.
   PubMed Web of Science ®Google Scholar
• LOWRY, 0. H., ROSEBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   Google Scholar
• MACKENZIE, P. I., OWENS, I. S., BURCHELL, B., BOCK, K. W., BAIROCH, A., BELANGER, A., FOURNEL-GIGLEUX, S., GREEN, M., Hum, D. W., IYANAGI, T., LANCET, D., LOUISOT, P., MAGDALOU, J., ROY, CHOWDURY, J., RITTER, J. K., SCHACHTER, H., TEPHLY, T. R., TIPTON, K. F. and NEBERT, D. W., 1997, The UDP glucuronosyl transferase gene superfamily: Recommended nomenclature based on evolutionary divergence. Pharmacogenetics, 7, 255–269.
   Google Scholar
• McGuRK, K. A., BRIERLEY, C. H. and BURCHELL, B., 1998, Drug glucuronidation by human renal UDP-glucuronosyltransferases. Biochemical Pharmacology, 55, 1005–1012.
   PubMed Web of Science ®Google Scholar
• MINERS, J. 0. and MACKENZIE, P. I., 1991, Drug glucuronidation in humans. Pharmacology and Therapy, 51, 347–369.
   Google Scholar
• PRENTIS, R. A., Lis, Y. and WALKER, S. R., 1988, Pharmaceutical innovation by seven UK-owned pharmaceutical companies (1964-1985). British Journal of Clinical Pharmacology, 25, 387–396.
   PubMed Web of Science ®Google Scholar
• RITTER, J. K., CHEN, F., SHEEN, Y. Y., LUBET, R. A. and OWENS, I. S., 1992, Two human liver cDNAs encode UDP-glucuronosyltransferases with 2 log differences in activity toward parallel substrates including hyodeoxycholic acid and certain estrogen derivatives. Biochemistry, 31, 3409–3414.
   PubMed Web of Science ®Google Scholar
• SOARS, M. G., RILEY, R. J., FINDLEY, K. A. B. and BURCHELL, B., 2001, Evidence for significant difference in microsomal drug glucuronidation by canine and human liver and kidney. Drug Metabolism and Disposition, 29, 121–126.
   Google Scholar
• SUTHERLAND, L., EBNER, T. and BURCHELL, B., 1993, The expression of UDP-glucuronosyltransferases of the UGT1 family in human liver and kidney in response to drugs. Biochemical Pharmacology, 45, 295–301.
   PubMed Web of Science ®Google Scholar
• TOWBIN, H., STRAEHLIN, T. and GORDON, J., 1979, Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences, USA, 76, 4350–4354.
   PubMed Web of Science ®Google Scholar
• WOOSTER, R., SUTHERLAND, L., EBNER, T., CLARKE, D., DA CRUZ E SILVA, 0. and BURCHELL, B., 1991, Cloning and stable expression of a new member of the human liver phenol/bilirubin:UDP-glucuronosyltransferase cDNA family. Biochemical Journal, 278, 465–469.
   Google Scholar